Malaga Cove Capital’s Bristol-Myers Squibb BMY Stock Holding History

Malaga Cove Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-35,189	Closed	-$2.44M	–	155
2023 Q1	$2.44M	Sell	35,189 -1	-0%	-$71	1.21%	20
2022 Q4	$2.53M	Sell	35,190 -241	-0.7%	-$18.2K	1.38%	14
2022 Q3	$2.52M	Buy	35,431 +68	+0.2%	+$4.93K	1.44%	12
2022 Q2	$2.72M	Hold	35,363	–	–	1.52%	11
2022 Q1	$2.58M	Sell	35,363 -415	-1%	-$27.9K	1.17%	20
2021 Q4	$2.23M	Buy	35,778 +3,758	+12%	+$220K	0.87%	33
2021 Q3	$1.9M	Buy	32,020 +1,923	+6%	+$127K	0.78%	42
2021 Q2	$2.01M	Buy	30,097 +200	+0.7%	+$13K	0.86%	36
2021 Q1	$1.9M	Buy	29,897 +320	+1%	+$19.9K	0.81%	39
2020 Q4	$1.82M	Buy	29,577 +4,422	+18%	+$272K	0.85%	29
2020 Q3	$1.52M	Buy	25,155 +142	+0.6%	+$8.55K	0.88%	29
2020 Q2	$1.47M	Buy	25,013 +60	+0.2%	+$3.59K	0.9%	29
2020 Q1	$1.4M	Buy	24,953 +3,366	+16%	+$206K	1.15%	17
2019 Q4	$1.39M	Buy	21,587 +1,891	+10%	+$108K	0.86%	30
2019 Q3	$999K	Buy	19,696 +3,973	+25%	+$187K	0.68%	50
2019 Q2	$713K	Buy	+15,723	New	+$732K	0.46%	80
2017 Q4	–	Sell	-1,400	Closed	-$90K	–	131
2017 Q3	$90K	Buy	+1,400	New	+$81.7K	0.05%	123

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Malaga Cove Capital's BMY Position: Q2 2023 in Review

Malaga Cove Capital sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 35,189 shares — an estimated $2.44M sold.

Malaga Cove Capital first reported a position in BMY in Q3 2017 and held it in 17 quarters. The position peaked at $2.72M in Q2 2022. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Malaga Cove Capital reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Malaga Cove Capital sold 35,189 Bristol-Myers Squibb shares in Q2 2023, an estimated $2.44M.
Malaga Cove Capital first reported a position in Bristol-Myers Squibb in Q3 2017 and held it in 17 quarters.
Malaga Cove Capital's Bristol-Myers Squibb position peaked at $2.72M in Q2 2022.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Malaga Cove Capital's 13F filing for Q2 2023, filed 2 Aug 2023.